| Medical and Health Sciences | 2021-2025 | 192 | DE 10 | 99.96 |
| Hematology | Lifetime | 76 | DE 7 | 99.57 |
| Medical Genetics | Lifetime | 186 | DE 24 | 98.68 |
| Hematology | 2021-2025 | 7 | DE 1 | 99.90 |
| Medical Genetics | 2021-2025 | 22 | DE 5 | 99.45 |
| Oncology | 2021-2025 | 311 | DE 19 | 97.07 |
| Molecular Biology | 2021-2025 | 732 | DE 38 | 95.98 |
| Immunology | 2021-2025 | 520 | DE 36 | 85.21 |
| Acute Myeloid Leukemia Research | Lifetime | 73 | DE 12 | 99.73 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 44 | DE 7 | 99.50 |
| Hematopoietic Stem Cell Transplantation | Lifetime | 102 | DE 12 | 99.43 |
| Hemoglobinopathies and Related Disorders | Lifetime | 124 | DE 6 | 98.84 |
| Hematological disorders and diagnostics | Lifetime | 70 | DE 5 | 98.68 |
| Chronic Myeloid Leukemia Treatments | Lifetime | 164 | DE 20 | 99.10 |
| Acute Lymphoblastic Leukemia research | Lifetime | 233 | DE 25 | 99.06 |
| Blood disorders and treatments | Lifetime | 113 | DE 11 | 98.25 |
| Multiple Myeloma Research and Treatments | Lifetime | 391 | DE 23 | 97.81 |
| Retinoids in leukemia and cellular processes | Lifetime | 299 | DE 18 | 97.37 |
| Bone and Joint Diseases | Lifetime | 298 | DE 20 | 97.57 |
| Histone Deacetylase Inhibitors Research | Lifetime | 386 | DE 31 | 96.42 |
| Neutropenia and Cancer Infections | Lifetime | 498 | DE 48 | 95.95 |
| Erythropoietin and Anemia Treatment | Lifetime | 536 | DE 40 | 92.79 |
| Kruppel-like factors research | Lifetime | 807 | DE 47 | 88.11 |
| Drug-Induced Ocular Toxicity | Lifetime | 926 | DE 48 | 64.88 |
| Hemoglobinopathies and Related Disorders | 2021-2025 | 2 | DE 1 | 99.53 |
| Acute Myeloid Leukemia Research | 2021-2025 | 9 | DE 1 | 99.92 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | 2021-2025 | 4 | DE 1 | 99.79 |
| Hematopoietic Stem Cell Transplantation | 2021-2025 | 26 | DE 4 | 99.24 |
| Chronic Myeloid Leukemia Treatments | 2021-2025 | 35 | DE 2 | 99.32 |
| Acute Lymphoblastic Leukemia research | 2021-2025 | 68 | DE 3 | 98.61 |
| Retinoids in leukemia and cellular processes | 2021-2025 | 12 | DE 1 | 96.70 |
| Neutropenia and Cancer Infections | 2021-2025 | 35 | DE 3 | 96.98 |
| Histone Deacetylase Inhibitors Research | 2021-2025 | 51 | DE 3 | 96.18 |
| Hematological disorders and diagnostics | 2021-2025 | 24 | DE 3 | 93.59 |
| CAR-T cell therapy research | 2021-2025 | 476 | DE 40 | 97.09 |
| Multiple Myeloma Research and Treatments | 2021-2025 | 214 | DE 12 | 96.96 |
| Blood disorders and treatments | 2021-2025 | 49 | DE 7 | 94.55 |
| Kruppel-like factors research | 2021-2025 | 55 | DE 6 | 91.41 |
| Lymphoma Diagnosis and Treatment | 2021-2025 | 820 | DE 62 | 93.24 |
| Protein Degradation and Inhibitors | 2021-2025 | 442 | DE 25 | 91.48 |
| Immune cells in cancer | 2021-2025 | 831 | DE 36 | 88.89 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 578 | DE 24 | 81.18 |
| Vascular Tumors and Angiosarcomas | 2021-2025 | 299 | DE 14 | 76.21 |
| Bone and Joint Diseases | 2021-2025 | 774 | DE 40 | 73.62 |
| Erythrocyte Function and Pathophysiology | 2021-2025 | 739 | DE 34 | 72.36 |
| Viral Infectious Diseases and Gene Expression in Insects | 2021-2025 | 971 | DE 131 | 71.31 |
| Erythropoietin and Anemia Treatment | 2021-2025 | 472 | DE 32 | 67.14 |
| Drug-Induced Ocular Toxicity | 2021-2025 | 143 | DE 3 | 53.84 |
